Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
The closing price of Candel Therapeutics Inc (NASDAQ: CADL) was $5.57 for the day, up 0.54% from the previous closing price of $5.54. In other words, the price has increased by $0.54 from its previous closing price. On the day, 1.13 million shares were traded. CADL stock price reached its highest trading level at $5.65 during the session, while it also had its lowest trading level at $5.51.
Ratios:
Our analysis of CADL’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 8.25 and its Current Ratio is at 8.25. In the meantime, Its Debt-to-Equity ratio is 0.09 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In the most recent recommendation for this company, Stephens on October 28, 2025, initiated with a Overweight rating and assigned the stock a target price of $15. On September 03, 2025, BofA Securities Downgraded its rating to Neutral which previously was Buy but kept the price unchanged to $7.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jul 28 ’25 when Nichols William Garrett sold 937 shares for $6.98 per share. The transaction valued at 6,540 led to the insider holds 52,493 shares of the business.
Nichols William Garrett sold 781 shares of CADL for $3,936 on Jun 30 ’25. The Chief Medical Officer now owns 52,493 shares after completing the transaction at $5.04 per share. On Jun 30 ’25, another insider, WILLIAM GARRETT NICHOLS, who serves as the Officer of the company, bought 3,593 shares for $4.90 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CADL now has a Market Capitalization of 305783552 and an Enterprise Value of 226027552.
Stock Price History:
The Beta on a monthly basis for CADL is -0.93, which has changed by -0.35457706 over the last 52 weeks, in comparison to a change of 0.14402747 over the same period for the S&P500. Over the past 52 weeks, CADL has reached a high of $13.68, while it has fallen to a 52-week low of $4.25. The 50-Day Moving Average of the stock is 5.98%, while the 200-Day Moving Average is calculated to be -1.17%.
Shares Statistics:
CADL traded an average of 849.12K shares per day over the past three months and 1205480 shares per day over the past ten days. A total of 54.90M shares are outstanding, with a floating share count of 41.06M. Insiders hold about 25.21% of the company’s shares, while institutions hold 36.98% stake in the company. Shares short for CADL as of 1764288000 were 8272637 with a Short Ratio of 9.74, compared to 1761868800 on 7479907. Therefore, it implies a Short% of Shares Outstanding of 8272637 and a Short% of Float of 19.03.
Earnings Estimates
As of right now, 2.0 analysts gave their recommendation on the stock of the company. The consensus estimate for the next quarter is -$0.21, with high estimates of -$0.17 and low estimates of -$0.25.
Analysts are recommending an EPS of between -$0.41 and -$0.8 for the fiscal current year, implying an average EPS of -$0.61. EPS for the following year is -$0.5, with 1.0 analysts recommending between -$0.5 and -$0.5.
